Registered Members Login:
Forgotten Your Details? Click Here To Recover +
Welcome To The ShareCafe Community - Talk Shares And Take Stock With Smart Investors - New Here? Click To Register >

38 Pages (Click to Jump) V   1 2 3 4 > »    
Reply to this topic

post Posted: Apr 4 2011, 02:26 PM
  Quote Post

Posts: 2,621
Thanks: 103

In Reply To: moosey's post @ Jul 30 2009, 03:04 PM

what is the difference between HTW on the ASX
Heartware International on the NYSE?
I note that HTw on the ASx has a market cap of 117million
and on the NYSE it is 80$ x 17million shares. = 1.3 billion$

Just asking because I am confused.

post Posted: Jul 30 2009, 03:04 PM
  Quote Post

Posts: 4,116
Thanks: 676

In Reply To: forrestgump's post @ Feb 22 2009, 01:41 PM

This was posted by AIMD on HC.
FTC blocks HeartWare deal

Nick Evans
Thursday, 30 July 2009

THE US Federal Trade Commission will act to prevent Thoratec’s takeover of HeartWare, according to the two companies – the second time the regulator has acted to prevent a merger involving an Australian life science company this year, after it blocked CSL’s plans to acquire Talecris earlier this year.

In a statement to the Australian Securities Exchange this morning, HeartWare said the FTC would take action in a US Federal District Court to challenge the $429 million takeover deal, first announced in February.

The companies gave no reason for the mooted challenge, saying only that they were “disappointed” in the FTC’s decision, and that they would review it and “mutually assess the appropriate steps” to take in response.

The FTC’s website has been down since this morning, and no statement is currently available on why the regulator has decided to challenge the acquisition.

All posters Please note, the decision to either buy or sell this share is entirely the individuals choice, I am not authorised to give investment advice, I post here to discuss the merits of technology as I see it, which may or may not be correct? and any information here is worth what you paid for it! the moose is loose
post Posted: Feb 22 2009, 01:41 PM
  Quote Post

Posts: 2,916
Thanks: 632

US firm Thoratec Cor has snapped up listed Australian medical device company HeartWare for $US282million ($427.5million) in cash and stock.

The California-based Thoratec will pay $1.32 per share, half of which will be paid in cash and the rest in Thoratec stock, according to HeartWare chief financial officer David McIntyre.

Thoratec, which makes a mechanical heart the size of a D-cell battery, has also agreed to a $US28 million loan to HeartWare.

HeartWare shares have been in a trading halt since Friday. They closed at 0.665c.

Thoratec is buying HeartWare for its experimental heart pump used for patients with heart failure.

HeartWare's implantable pump has been approved for sale in Europe and the company has started enrolling patients in the US for tests.

Thoratec chief executive Gary Burbach said: "This transaction is a positive development for heart failure patients and (their) clinicians. (It) combines Thoratec's ... devices with HeartWare's innovative technologies."

While the transaction will dilute Thoratec's earnings into 2011, it expects to book a one-time charge of $US15 million to $US20 million this year, according to a statement.

Thoratec's pump, called HeartMate II, is approved in the US for patients awaiting transplants.

HeartWare says its pump, one of the smallest in the world, helps keep patients alive until a transplant is available.

US venture capitalist Appletree Partners is HeartWare's biggest shareholder, with 30 per cent.


Try to be as good a person as your dog thinks you are.
post Posted: Oct 27 2008, 06:58 PM
  Quote Post

Posts: 3,002
Thanks: 29

In reply to: grippm on Monday 27/10/08 02:22pm


post Posted: Oct 27 2008, 02:22 PM
  Quote Post

Posts: 11

In reply to: dory on Friday 24/10/08 08:09pm

Dory are u the person who use to bag htw on hotcopper while pushing VCR?

post Posted: Oct 24 2008, 08:09 PM
  Quote Post

Posts: 3,002
Thanks: 29

HeartWare beats for US

WHILE a local competitor languishes, medical device maker HeartWare is charging ahead, with shareholders voting to approve a plan to relocate the business to the US.

Currently registered in both countries, HeartWare will ultimately become a US-incorporated venture with a listing on the Australian Securities Exchange.

The move, which comes on the back of a $31 million capital raising and approval to start US trials of its heart pump as a bridging device for patients waiting for a heart transplant, is expected to pave the way for a dual listing on the Nasdaq exchange.

In contrast, coming up with the dosh to fund its $28 million a year operations is proving quite a headache for the board of rival Ventracor, led by former Qantas boss John Ward.

Luckily he has a director on side who is used to dealing with some corporate pain -- Elizabeth Nosworthy, chairwoman of the beleaguered Babcock & Brown.

While Nosworthy no doubt has a lot on her plate these days, she should consider asking Ventracor's IT department to update her biographical details on the company's website, which has her listed as chairwoman of junior telco Commander Communications, which collapsed earlier this year in a steaming heap of debt.

That's hardly the best advertisement to the new investors that Ventracor is desperate to attract.

Share Cafe Sentifi Top themes and market attention on:

post Posted: Oct 22 2008, 08:00 PM
  Quote Post

Posts: 107
Thanks: 4

Everybody have a LOOK at the market depth this stock is going no where.

post Posted: Oct 22 2008, 12:52 PM
  Quote Post

Posts: 5,264
Thanks: 1136

In reply to: grippm on Wednesday 22/10/08 09:41am

asx announcement..

Redomiciliation Meeting Results

post Posted: Oct 22 2008, 09:11 AM
  Quote Post

Posts: 11

In reply to: dory on Sunday 05/10/08 11:47am

This pump offers something that no other pump offers. It has
the potential to make an important difference for our patients
and on the market.
» O. H. (Bud) Frazier M.D.; at HeartWare Investigators’ meeting held on 10
October 2008
Caution – Investigational Device, Limited by United States Law to Investigational Use

post Posted: Oct 5 2008, 11:47 AM
  Quote Post

Posts: 3,002
Thanks: 29

chart-wise htw looks set to go this week with buyers at .62 ? see how this week un-folds ?


38 Pages (Click to Jump) V   1 2 3 4 > » 

Back To Top Of Page
Reply to this topic

You agree through the use of ShareCafe, that you understand and accept the TERMS OF USE.